GIANT CELL ARTERITIS
Clinical trials for GIANT CELL ARTERITIS explained in plain language.
Never miss a new study
Get alerted when new GIANT CELL ARTERITIS trials appear
Sign up with your email to follow new studies for GIANT CELL ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot could help patients with rare artery disease avoid relapse
Disease control CompletedThis study tested a drug called secukinumab in 151 adults aged 50 and older with newly diagnosed giant cell arteritis (GCA), a condition that causes inflammation in arteries. Participants were in remission and received either secukinumab or a placebo, along with a standard steroi…
Matched conditions: GIANT CELL ARTERITIS
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New IV drug shows promise for inflammatory conditions in early trial
Disease control CompletedThis early-stage study tested an intravenous (IV) form of secukinumab in 65 adults with giant cell arteritis (GCA) or polymyalgia rheumatica (PMR), two inflammatory conditions. The goal was to see how the drug moves through the body and whether it is safe. Participants received m…
Matched conditions: GIANT CELL ARTERITIS
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
New scan may replace needle biopsy for artery disease diagnosis
Diagnosis CompletedThis study tested whether a PET/CT scan of the head arteries can accurately diagnose giant cell arteritis, a condition that causes inflamed blood vessels. Researchers compared the scan results to those from ultrasound and MRI in 70 patients over 50. The goal was to see if this no…
Matched conditions: GIANT CELL ARTERITIS
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Diagnosis
Last updated May 01, 2026 16:00 UTC
-
Could a low-dose addiction drug ease vasculitis symptoms?
Symptom relief CompletedThis study tested whether a very low dose of naltrexone, a drug normally used for alcoholism, can improve physical health and quality of life in people with vasculitis (a group of rare blood vessel diseases). Sixty adults with different types of vasculitis took either the drug or…
Matched conditions: GIANT CELL ARTERITIS
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Apr 29, 2026 15:05 UTC